Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 7 for:    depot | Age-Related Macular Degeneration
Previous Study | Return to List | Next Study

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03249740
Recruitment Status : Recruiting
First Posted : August 15, 2017
Last Update Posted : June 28, 2018
Sponsor:
Information provided by (Responsible Party):
Graybug Vision

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2020
  Estimated Study Completion Date : March 2020